Search results for "Host"

showing 10 items of 1982 documents

The structure of parasite component communities in brackish water fishes of the northeastern Baltic Sea

2001

We used nestedness analysis to seek non-random patterns in the structure of component communities of metazoan parasites collected from 31 sympatric fish species from the northeastern Bothnian Bay, the most oligohaline area of the Baltic Sea. Only 8 marine parasite species were found among the 63 species recorded, although some marine fish species reproduce in the bay and others occasionally visit the area. Marine parasite species can utilize both freshwater and marine fish species as intermediate or final hosts, and marine fish can harbour freshwater parasite species. This exchange of parasite species between marine and freshwater fish has probably resulted from ecological factors acting ov…

Oceans and SeasGeneralist and specialist speciesHost-Parasite InteractionsFish DiseasesCrustaceaHelminthsLeechesAnimalsParasitesSeawaterMolluscaEcosystembiologyEcologyFishesAquatic animalbiology.organism_classificationInfectious DiseasesMolluscaSympatric speciationFreshwater fishNestednessAnimal Science and ZoologyParasitologySpecies richnessHelminthiasis AnimalBayParasitology
researchProduct

Baculovirus infection affects caterpillar chemoperception

2021

International audience; Baculoviruses are double-stranded DNA entomopathogenic viruses that infect predominantly insects of the order Lepidoptera. Research in the last decade has started to disentangle the mechanisms underlying the insect-virus interaction, particularly focusing on the effects of the baculovirus infection in the host's physiology. Among crucial physiological functions, olfaction has a key role in reproductive tasks, food source detection and enemy avoidance. In this work, we describe that Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV) induces expression changes in some odorant receptors (ORs)-the centrepiece of insect's olfaction-when infecting larvae from its nat…

OlfactionSpodopteraSpodopteraReceptors OdorantBiochemistryLepidoptera genitalia03 medical and health sciences0302 clinical medicineExiguaAnimalsBehaviour[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyBaculovirusMolecular Biology030304 developmental biologyNeuronsGenetics0303 health sciencesbiologyOdorant receptorsHost (biology)fungibiology.organism_classificationOlfactionNucleopolyhedrovirusesBeet armywormDrosophila melanogasterLarvaInsect ScienceInsect ProteinsNoctuidaeCaterpillarHeterologous expressionDrosophila melanogaster030217 neurology & neurosurgeryInsect Biochemistry and Molecular Biology
researchProduct

A polymorphism in the TYMP gene is associated with the outcome of HLA-identical sibling allogeneic stem cell transplantation.

2013

Thymidine phosphorylase (TYMP), an enzyme involved in nucleotide synthesis, has been implicated in critical biological processes such as DNA replication, protection against mutations, and tissue repair. In this work, we retrospectively evaluated the influence of a polymorphism in the TYMP gene (rs112723255; G/A) upon the outcome of 448 patients subjected to allogeneic stem cell transplantation (allo-SCT) from an human leukocyte antigen (HLA)-identical sibling donor. The TYMP genotype of patients correlated with overall survival—carriers of the minor allele (A) being at an increased risk of dying after transplantation (hazard ratio, HR = 1.9; P = 0.004). This effect was mostly due to differe…

OncologyAdultMalemedicine.medical_specialtyTime FactorsAdolescentGenotypeGraft vs Host DiseaseHuman leukocyte antigenDiseaseBiologyRisk FactorsInternal medicineGenotypemedicineHumansTransplantation HomologousAlleleChildAllelesAgedRetrospective StudiesThymidine PhosphorylasePolymorphism GeneticHistocompatibility TestingSiblingsHazard ratioInfantHematologyMiddle AgedMinor allele frequencyTransplantationSurvival RateChild PreschoolHematologic NeoplasmsImmunologyChronic DiseaseFemaleComplicationStem Cell TransplantationAmerican journal of hematology
researchProduct

P043 HLA-DPB matching and donor cytomegalovirus positive (CMV+) status: An “unconventional alliance” associated with a decreased relapse incidence in…

2017

Aim While the role of HLA-DPB1 (DP) compatibility in uHSCT regarding graft versus host disease (GVHD)- and graft versus leukaemia (GVL)-effects has been extensively discussed, its interaction with donor CMV status (dCMV), remains elusive. The aim of this study was, to investigate the impact of dCMV status in DP matched (DPM) and mismatched (DPMM) uHSCT. Methods 1749 HSCT transplant (Tx) pairs were DP genotyped with an exon 2 amplicon based NGS approach in order to assess their DP matching status. CMV sero-status as well as clinical data were retrieved from the German Stem Cell Registry. Overall survival (OS), relapse incidence (RI) and chronic GvHD (cGvHD) were defined as endpoints, while s…

OncologyCMV statusmedicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.medical_treatmentImmunologyGeneral MedicineHuman leukocyte antigenHematopoietic stem cell transplantationmedicine.disease3. Good healthGraft-versus-host diseaseStatistical significanceInternal medicineImmunologyImmunology and AllergyMedicinebusinessCytomegalovirus PositiveCohort studyHuman Immunology
researchProduct

Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogeno…

2020

The Acute Leukemia Working Party (ALWP) of the EBMT assessed the outcome of allogeneic stem cell transplantation (alloSCT) in patients with relapsed/refractory AML (r/rAML) evaluating six sequential conditioning regimens (SR) groups. A total of 2132 patients were included. LFS at 2 years was 28.9%, 33.6%, 35.3%, 20.6%, 24.4%, and 27% for the FLAMSA-TBI4, FLAMSA-Chemo, Mel-Flu-TBI8, Mel-Treo-Flu, Thio-ETO-Cy-Bu2-Flu, and Clo-ARAC-(Bu2/TBI4)-Cy groups, respectively. In patients55 years of age Mel-Flu-TBI8 had the best LFS, which was statistically significant only in comparison to the Mel-Treo-Flu group, while in patients ≥55 years LFS was best with FLAMSA-Chemo without significant differences…

OncologyCancer Researchmedicine.medical_specialtyTransplantation ConditioningMedizinGraft vs Host Disease03 medical and health sciencesMyelogenous0302 clinical medicineRefractoryhemic and lymphatic diseasesInternal medicinemedicineHumansIn patientBusulfanAgedRetrospective StudiesAcute leukemiabusiness.industryHematopoietic Stem Cell TransplantationHematologyMiddle Agedmedicine.diseaseTransplantationLeukemia Myeloid AcuteLeukemiaOncology030220 oncology & carcinogenesisRelapsed refractoryStem cellbusiness030215 immunologyLeukemia & Lymphoma
researchProduct

CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >5…

2018

Reduced-intensity conditioning (RIC) and T cell depletion (TCD) through CD34+ cell selection without the use of post-transplantation immunosuppression are 2 strategies used to reduce nonrelapse mortality (NRM) in older patients after allogeneic hematopoietic cell transplantation (allo-HCT). To compare the efficacy of the RIC and TCD approaches, we evaluated the outcomes of patients age >50 years with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) who underwent allo-HCT from an HLA-matched donor with one of these strategies. Baseline characteristics were comparable in the patients receiving TCD (n = 204) and those receiving RIC (n = 151), except for a higher proportion o…

OncologyMalemedicine.medical_specialtyTransplantation Conditioningmedicine.medical_treatmentCD34GVHDGraft vs Host DiseaseAntigens CD34Lymphocyte Depletion03 medical and health sciencesMyelogenous0302 clinical medicineRecurrencehemic and lymphatic diseasesInternal medicinemedicineHumansTransplantation HomologousIn patientAgedRetrospective StudiesTransplantationHematopoietic cellbusiness.industryRICHematopoietic Stem Cell TransplantationImmunosuppressionT-cell depletionHematologyAllogeneic hematopoietic cell transplantationMiddle AgedMyeloablative Agonistsmedicine.diseaseTransplantationLeukemiaLeukemia Myeloid Acute030220 oncology & carcinogenesisMyelodysplastic SyndromesFemalebusinessT cell depletion030215 immunology
researchProduct

Flower lose, a cell fitness marker, predicts COVID‐19 prognosis

2021

Abstract Risk stratification of COVID‐19 patients is essential for pandemic management. Changes in the cell fitness marker, hFwe‐Lose, can precede the host immune response to infection, potentially making such a biomarker an earlier triage tool. Here, we evaluate whether hFwe‐Lose gene expression can outperform conventional methods in predicting outcomes (e.g., death and hospitalization) in COVID‐19 patients. We performed a post‐mortem examination of infected lung tissue in deceased COVID‐19 patients to determine hFwe‐Lose’s biological role in acute lung injury. We then performed an observational study (n = 283) to evaluate whether hFwe‐Lose expression (in nasopharyngeal samples) could accu…

OncologyMedicine (General)medicine.medical_specialtyFlowersDiseaseQH426-470Lung injurySeverity of Illness Indexcell fitnessArticleR5-920COVID‐19Internal medicineSeverity of illnessGeneticsmedicineHumansPandemicsRetrospective StudiesReceiver operating characteristicSARS-CoV-2business.industryCOVID-19Retrospective cohort studyArticlesTriageMicrobiology Virology & Host Pathogen InteractionflowerROC CurvebiomarkerMolecular MedicineBiomarker (medicine)Observational studyprognosisbusinessBiomarkersEMBO Molecular Medicine
researchProduct

Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies a…

2019

Of the two human herpesvirus 6 (HHV-6) species, human herpesvirus 6B (HHV-6B) encephalitis is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplant. Guidelines for the management of HHV-6 infections in patients with hematologic malignancies or post-transplant were prepared a decade ago but there have been no other guidelines since then despite significant advances in the understanding of HHV-6 encephalitis, its therapy, and other aspects of HHV-6 disease in this patient population. Revised guidelines prepared at the 2017 European Conference on Infections in Leukaemia covering diagnosis, preventative strategies and management of HHV-6 disease are n…

Oncologymedicine.medical_specialtyHHV-6 Infectionmedicine.medical_treatmentvirusesHerpesvirus 6 HumanGraft vs Host DiseaseRoseolovirus InfectionsDiseaseHematopoietic stem cell transplantationAntiviral AgentsGuideline ArticleImmunocompromised HostInternal medicinemedicineCombined Modality TherapyHumansIn patientbiologybusiness.industryHematopoietic Stem Cell Transplantationvirus diseasesHematologybiochemical phenomena metabolism and nutritionbiology.organism_classificationmedicine.diseaseCell Transformation ViralCombined Modality TherapyEuropeTreatment OutcomeHematologic NeoplasmsPractice Guidelines as TopicHuman herpesvirus 6Allogeneic hematopoietic stem cell transplantbusinessEncephalitisHaematologica
researchProduct

Durable Molecular Remissions in Patients with Relapsed CML Post Allogeneic Stem Cell Transplantation upon Treatment with Imatinib-Mesylate (Glivec®, …

2004

Abstract Purpose: In a phase II clinical trial we have previously reported on the safety and efficacy of imatinib mesylate (IM) to induce hematologic, cytogenetic and molecular remissions in case of relapse post allogeneic stem cell transplantation (SCT) in patients with chronic myelogenous leukaemia (CML). Here we report on an extended follow-up phase, which was performed to monitor stability of responses and further disease course in patients enrolled. Patients and Methods: Within the trial, patients, transplanted in chronic phase (CP) CML with molecular or cytogenetic relapse (n=37), received IM at a starting dose of 400mg. Close monitoring was performed, which, besides evaluation of sid…

Oncologymedicine.medical_specialtyHematologybusiness.industryImmunologyContext (language use)Cell BiologyHematologymedicine.diseaseBiochemistryDiscontinuationSurgeryClinical trialTransplantationImatinib mesylateGraft-versus-host diseaseInternal medicinemedicinebusinessProgressive diseaseBlood
researchProduct

Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available The…

2020

BACKGROUND aGVHD, a common complication of allogeneic stem cell transplant (alloSCT), is driven by proinflammatory cytokines and chemokines that activate the immune system, resulting in end-organ damage. Steroids are first-line treatment but up to 50% of pts are steroid refractory (SR), resulting in high mortality and morbidity. RUX, a JAK1/JAK2 inhibitor, inhibits cytokine-dependent activation of the JAK-STAT pathway and cell proliferation and differentiation, which prevents worsening of aGVHD and allows recovery. JAK pathway inhibition by RUX may also lead to modulation of proinflammatory cytokines and prognostic GVHD biomarkers. The phase 3 randomized REACH2 trial (NCT02913261) in SR aGV…

Oncologymedicine.medical_specialtyRuxolitinibbusiness.industryImmunologyCell BiologyHematologyExploratory analysisSerum samplesBiochemistryInternal medicinemedicineCurrent employmentIn patientHost diseasebusinessSteroid refractoryhealth care economics and organizationsTreatment Armmedicine.drugBlood
researchProduct